dm+d

10099000

Articles

Safety in Lactation: Drugs for the relief of soft-tissue inflammation and topical pain relief

28 October 2020Topical formulations of non-steroidal anti-inflammatories (NSAIDS) and capsaicin produce low systemic levels in the mother. Although there is no direct evidence, subsequent milk levels are…

Safety in Lactation: Non-steroidal anti-inflammatory drugs

23 September 2020There is very limited information on the use of NSAIDs during breastfeeding; ibuprofen and diclofenac are the preferred choices due to their extensive safe use…
Search Articles

Medicine Compliance Aid Stability

OrudisSanofi-Aventis

Sanofi-Aventis
Orudis
Capsules 50mg, 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
12 August 2015

OruvailSanofi-Aventis

Sanofi-Aventis
Oruvail
Capsules 100mg, 150mg, 200mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
12 August 2015

TiloketTillomed

Tillomed
Tiloket
Capsules 50mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
1 October 2015

Tiloket CRTillomed

Tillomed
Tiloket CR
Capsules 100mg, 200mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
1 October 2015

Lactation Safety Information

Ibuprofen, Diclofenac
Very limited published evidence of safety
Negligible amounts in breast milk
30 July 2020

Topical

Topical
Yes
Negligible milk levels anticipated as systemic absorption from topical formulations is low
Follow normal precautions for topical medicines (see summary)
30 July 2020